semaglutide is pink as a MASH Treatment: What You Need to Know The FDA Warns of the

Manufactured through controlled production workflows, each lot is handled under internal quality procedures designed to support consistency, documentation, and traceability

These medications are designed to be effective when injected into any of the approved subcutaneous sites, with product information confirming no clinically relevant differences in medication exposure between the recommended injection areas

Levothyroxine : Co-administration with semaglutide increases thyroxine exposure

Limitations of Use: DDAVP Nasal Spray is not indicated for: Treatment of nephrogenic diabetes insipidus, Treatment of primary nocturnal enuresis [see Warnings and Precautions (5.1)], Use in patients with conditions that compromise the intranasal route of administration (e.g., severe nasal congestion and blockage, nasal mucosa atrophy, severe atrophic rhinitis, recent nasal surgery such as transsphenoidal hypophysectomy) [see Warnings and Precautions (5.2)]